MARIANNE NELSON: Open Payments
NPI 1861120180 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 45 payments from 12 companies in 2025. Trend: 2023 $231 · 2024 $716 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $180 |
| CSL Behring | 4 | $115 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Calliditas Therapeutics US Inc. | 2 | $46 |
| Fresenius USA Marketing, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
Products named: TAVNEOS, Hizentra, JYNARQUE, TARPEYO, VELPHORO, BENLYSTA, Vanrafia, VOYXACT.
Industry payments across ID — which companies pay providers there.
